ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

NCI renews Roswell Park’s core grant for five years.

September 26, 2003

Surgical Oncology Planners Develop NCPP research Approaches, Projects

May 24, 1974